Concomitant Medication (CM) is an Interventions domain is used to represent information relating to concomitant and prior medications used by the subject, such as those given on an as-needed basis or condition-appropriate medications. Thesame basic data collection variables should be collected for all medications, treatments, and therapies (prior, general concomitant medications, and medications of interest). Recreational substances are not represented in this domain (see Section 3.3.2.7, Prior Usage of Recreational Products (Including Tobacco Products) (SU, FASU, CM, FACM)), but rather medical products recognized to reduce nicotine dependence (e.g., nicotine replacement patches).
Example
This is an example CRF used to collect general concomitant medications/products in a study. This CRF was designed to allow the applicant to use either CMENRF or CMENRTPT to represent an intervention was ongoing. In order to save space, some of the example permissible values are only shown in the metadata specifications.
This is the metadata specifications for Section 1 and 2 of the CRF.
Section 1
Order
Question Text
Prompt
Case Report Form Completion Instructions
Type
Collection Variable
Tabulation Target
Mapping Instructions
Controlled Terminology CodeList Name
Permissible Values
Pre-Populated Value
1
Were any concomitant medications/products taken?
Any Concomitant Medications/Products
Indicate if the subject took any concomitant medications/products. If Yes, include the appropriate details where indicated on the CRF.
Text
Not Submitted
(NY)
Section 2
Order
Question Text
Prompt
Case Report Form Completion Instructions
Type
Collection Variable
Tabulation Target
Mapping Instructions
Controlled Terminology CodeList Name
Permissible Values
Pre-Populated Value
2
What is the category for the concomitant medication/product?
Concomitant Medication/Product Category
Record the medication/product category, if not pre-printed on the CRF.
Text
CMCAT
CMCAT
GENERAL
3
What is the medication/product line number?
CM Line Number
If collected on the CRF, applicant may insert instructions to ensure each record has a unique identifier.
Text
CMSPID
CMSPID
4
What was the medication/product?
Medication/Product
Record only one medication/product per line. Provide the full trade or proprietary name of the medication/product; otherwise, record the generic name.
Text
CMTRT
CMTRT
5
For what indication was the medication/product taken?
Indication
Record the reason the medication/product was taken based on clinical investigator's evaluation. If taken to treat a condition, and a diagnosis was made, the indication should be the diagnosis. If taken to treat a condition, and no diagnosis was made, the indication should be the signs and symptoms. If taken as prophylaxis, report as "Prophylaxis for " and include a description of the condition(s).
Text
CMINDC
CMINDC
6
What was the individual dose of the medication/product?
Dose
Record the dose of medication/treatment per administration (e.g., 200).
Text
CMDOSTXT OR CMDOSE
CMDOSTXT/ CMDOSE
7
What is the unit?
Unit
Record the dose unit of the dose of medication/product taken (e.g., mg).
Text
CMDOSU
CMDOSU
(UNIT)
CAPSULE; g; IU; mg; mL; PUFF; TABLET; ug
8
What was the dose form of the medication/product?
Dose Form
Record the pharmaceutical dosage form (e.g., TABLET CAPSULE, SYRUP) of delivery for the medication/product taken.
Record the date the medication/treatment was first taken using this format. If the subject has been taking the medication/product for a considerable amount of time prior to the start of the study, it is acceptable to have an incomplete date. Medications/Products taken during the study are expected to have a complete start date. Prior medications/products that are exclusionary should have both a start date and an end date.
Date
CMSTDTC
CMSTDAT
12
Is the medication ongoing?
Ongoing
Record the medication/product as ongoing if the subject has not stopped taking the medication/product at the time of data collection and the end date should be left blank.
Text
CMENRF OR CMENRTPT
CMENRF or CMENRTPT
(NY)
No; Yes
13
What was the end date?
End Date
Record the date the medication/product was stopped using this format. If the subject has not stopped taking the medication/product leave this field blank.
Date
CMENDTC
CMENDAT
This is the SDTM dataset associated with the above example CRF. This SDTM dataset used CMENRF to represent ongoing interventions. More information can be found in Section 2.8.7.6, Representing References and Relative Timing.
The applicant included CMDECOD. The applicant is required to provide the dictionary name and version in the Define-XML document.
Rows 1-4:
The subject reported each instance of aspirin use. The frequency of each instance is represented in CMDOSFRQ and is ONCE.
Rows 6-8:
The subject reports the use of 3 medications. Diovan and Zoloft were still being taken by the subject, Astelin was a nasal spray where 2 sprays were taken twice a day in each nostril. Note that only partial start dates are provided for Diovan and Zoloft.
Row 9:
The subject took aspirin with a frequency of "PRN". This approach assumes that knowing exactly when aspirin was used is not important for evaluating the product in this study.
cm.xpt
cm.xpt
Row
STUDYID
DOMAIN
USUBJID
CMSEQ
CMTRT
CMDECOD
CMINDC
CMCLAS
CMDOSE
CMDOSTXT
CMDOSU
CMDOSFRM
CMDOSFRQ
CMROUTE
CMSTDTC
CMENDTC
CMENRF
1
ABC123
CM
ABC123-0001
1
ASPIRIN
acetylsalicylic acid
MIGRAINE
ANALGESICS
100
mg
TABLET
ONCE
ORAL
2006-10-14
2006-10-14
2
ABC123
CM
ABC123-0001
2
ASPIRIN
acetylsalicylic acid
MIGRAINE
ANALGESICS
100
mg
TABLET
ONCE
ORAL
2006-10-15
2006-10-15
3
ABC123
CM
ABC123-0001
3
ASPIRIN
acetylsalicylic acid
MIGRAINE
ANALGESICS
100
mg
TABLET
ONCE
ORAL
2006-10-16
2006-10-16
4
ABC123
CM
ABC123-0001
4
ASPIRIN
acetylsalicylic acid
MIGRAINE
ANALGESICS
100
mg
TABLET
ONCE
ORAL
2006-10-17
2006-10-17
5
ABC123
CM
ABC123-0001
5
ASPIRIN
acetylsalicylic acid
MIGRAINE
ANALGESICS
100
mg
TABLET
ONCE
ORAL
2006-01-18
2006-01-18
6
ABC123
CM
ABC123-0002
1
DIOVAN
valsartan
HYPERTENSION
ANTIHYPERTENSIVES
20
mg
TABLET
BID
ORAL
2004
AFTER
7
ABC123
CM
ABC123-0002
2
ZOLOFT
sertraline
PANIC ATTACKS
PSYCHOANALEPTICS
50
mg
TABLET
OD
ORAL
2004-01
AFTER
8
ABC123
CM
ABC123-0002
3
ASTELIN
azelastine
INFLUENZA
NASAL PREPARATIONS
2 sprays in each nostril-137 mcg
mcg
SPRAY
BID
NASAL
2006-02-26
AFTER
9
ABC123
CM
ABC123-0002
4
ASPIRIN
acetylsalicylic acid
PAIN
ANALGESICS
100
mg
TABLET
PRN
ORAL
2004-01-01
AFTER
$warningHtml
Dataset Wrapper Debug Message
Please add a row column to your dataset.
Example
In this example, the applicant collected information on previous medically recognized products used to reducenicotine dependency at the baseline visit. The applicant only collected details on the last attempt to reducenicotine dependencyfor each type of product used. These products are represented in the Concomitant Medication (CM) domain.
Order
Question Text
Prompt
Case Report Form Completion Instructions
Type
Collection Variable
Tabulation Target
Mapping Instructions
Controlled Terminology CodeList Name
Permissible Values
Pre-Populated Value
1
What was the medically recognized product name?
Medication
Text
CMTRTC
CMTRT
DRUG USED IN NICOTINE DEPENDENCE
2
Pre-Specified Intervention
Text
CMPRESP
CMPRESP
Y
3
Did the subject previously use medically recognized products to reduce nicotine dependency?
Any Medically Rrecognized Products Taken For Nicotine Dependency
Indicate if the subject had used any medically recognized products to attempt to reduce nicotine dependency
Text
CMOCCUR
CMOCCUR
(NY)
No;Yes;Not Done
4
How many times did the subject attempt to use use medically recognized products to reduce nicotine dependency
Times the Subject Attempted to Reduce Nicotine Dependency
Record the number of times a subject attempted to use medically recognized products to reduce nicotine dependency
Text
FAORRES
FAORRES
FAORRES where FAOBJ ="MEDICATION USED IN NICOTINE DEPENDENCE" and FATEST= Total Number "
5
Category
Text
FACAT
FACAT
ATTEMPTS TO REDUCE NICOTINE DEPENDENCE
Order
Question Text
Prompt
Case Report Form Completion Instructions
Type
Collection Variable
Tabulation Target
Mapping Instructions
Controlled Terminology CodeList Name
Permissible Values
Pre-Populated Value
6
What is the category of the medication/product the subject used to attempt to reduce nicotine dependency?
Medication
Text
CMTRT
CMCAT
NICOTINE REPLACEMENT THERAPY: NOT A NRT
7
What is the medication/product subcategory, if not pre-printed on the CRF.
Subcategory
Applicant Defined
Text
CMSCAT
CMSCAT
LAST ATTEMPTED USE WITH THIS MEDICATION
8
What was the name of the medication/product the subject used to reduce nicotine dependency?
Medication
Record only one medication/product per line. Provide the full trade or proprietary name of the medication/product; otherwise, record the generic name.
Text
CMTRT
CMTRT
9
What was the duration of the medication/product used to reduce nicotine dependency for the last attempt?
Collected Duration
Provide the duration of the medication/product used.
Text
CMCDUR
CMDUR
10
What was the duration unit of the medication/product used to reduce nicotine dependency for the last attempt?
Collected Duration Unit
Select the appropriate duration unit of the medication/product used.
Text
CMCDURU
CMDUR
(UNIT)
DAYS; MONTHS; YEARS
These example SDTM datasets represent the data collected on the above CRF.
Rows 1, 3, 7, 9:
Show whether the subject has used any medications to help with nicotine dependence. This was prespecified on the CRF, hence CMPRESP="Y". The applicant assigned CMTRT to "DRUG USED IN NICOTINE DEPENDENCE" which was the category name in an external dictionary.
Rows 2, 4, 5, 6, 8:
Show the various medications that were used by subjects. CMSCAT is used to indicate that these data are associated with the last attempted use. CMDUR is the collected duration of the product use. This is used only if collected on the CRF and not derived from start and end date/times. CMDUR is provided using ISO 8601 duration notation. CMPRESP is null since the specific medication used is not prespecified.
cm.xpt
xx.xpt
Row
STUDYID
DOMAIN
USUBJID
CMSEQ
CMTRT
CMCAT
CMSCAT
CMPRESP
CMOCCUR
CMDTC
CMDUR
1
1234
CM
1234005
1
DRUG USED IN NICOTINE DEPENDENCE
Y
Y
2008-08-08
2
1234
CM
1234005
2
NICOTINE PATCH XYZ
NICOTINE REPLACEMENT THERAPY
LAST ATTEMPTED USE WITH THIS MEDICATION
P2M
3
1234
CM
1234006
1
DRUG USED IN NICOTINE DEPENDENCE
Y
Y
2008-11-12
4
1234
CM
1234006
2
NICOTINE GUM ABC
NICOTINE REPLACEMENT THERAPY
LAST ATTEMPTED USE WITH THIS MEDICATION
P3M
5
1234
CM
1234006
3
NICOTINE LOZENGES ABC
NICOTINE REPLACEMENT THERAPY
LAST ATTEMPTED USE WITH THIS MEDICATION
P2W
6
1234
CM
1234006
1
BUPROPION
DRUG USED IN REDUCING NICOTINE DEPENDENCE OTHER THAN NRTS
LAST ATTEMPTED USE WITH THIS MEDICATION
P1M
7
1234
CM
1234007
2
DRUG USED IN NICOTINE DEPENDENCE
Y
Y
2008-06-12
8
1234
CM
1234007
3
VARENICLINE
DRUG USED IN REDUCING NICOTINE DEPENDENCE OTHER THAN NRTS
LAST ATTEMPTED USE WITH THIS MEDICATION
P40D
9
1234
CM
1234012
1
DRUG USED IN NICOTINE DEPENDENCE
Y
N
2008-03-05
$warningHtml
Dataset Wrapper Debug Message
Please add a row column to your dataset.
FACM was used to represent the total number of times the subject attempted to reduce nicotine dependency using a medically acceptable product. Only subjects who had attempted to reduce nicotine dependence are included in the FACM dataset.
fa.xpt
facm.xpt
Row
STUDYID
DOMAIN
USUBJID
FASEQ
FATESTCD
FATEST
FAOBJ
FACAT
FAORRES
FASTRESC
FADTC
1
1234
FA
1234005
1
TOTNUM
Total Number
DRUG USED IN NICOTINE DEPENDENCE
ATTEMPTS TO REDUCE NICOTINE DEPENDENCE
4
4
2008-08-08
2
1234
FA
1234006
1
TOTNUM
Total Number
DRUG USED IN NICOTINE DEPENDENCE
ATTEMPTS TO REDUCE NICOTINE DEPENDENCE
5
5
2008-11-12
3
1234
FA
1234007
1
TOTNUM
Total Number
DRUG USED IN NICOTINE DEPENDENCE
ATTEMPTS TO REDUCE NICOTINE DEPENDENCE
3
3
2008-06-12
$warningHtml
Example
In this example, data were collected on the previous use of smoking cessation products at the baseline visit. This example illustrates the use of CMOCCUR and CMPRESP. The reason why a product was discontinued and any use in the last 14 days was of interest.
This example CRF has 2 sections: Questions in the first section focus on whether any smoking cessation product has been used, and the questions in the second section collect each individual product used. In order to save space, some of the permissible values are only shown in the metadata specifications.
Section 1
Order
Question Text
Prompt
Case Report Form Completion Instructions
Type
Collection Variable
Tabulation Target
Mapping Instructions
Controlled Terminology CodeList Name
Permissible Values
Pre-Populated Value
1
What is the category for the medication?
Concomitant Medication Category
Text
CMCAT
SMOKING CESSATION PRODUCT
2
Were any smoking cessation products taken?
Any Smoking Cessation Products Taken
Indicate if the subject took any smoking cessation products If yes, include the appropriate details where indicated on the CRF.
Text
CMOCCUR
CMOCCUR;
(NY)
No;Yes
Section 2 For each smoking cessation product. If multiple other products are used, create a row for each other product.
Order
Question Text
Prompt
Case Report Form Completion Instructions
Type
Collection Variable
Tabulation Target
Mapping Instructions
Controlled Terminology CodeList Name
Permissible Values
Pre-Populated Value
3
What was the smoking cessation product used?
Smoking Cessation Product
Select the smoking cessation product.
Text
CMTRT
CMTRT
CMTRT; CMPRESP; If CMTRT="OTHER" Then CMTRT and CMPRESP are NULL.
Did the subject previously use the selected medication/product for smoking cessation?
Smoking Cessation Product Used
Indicate if the subject had used the selected smoking cessation product
Text
CMOCCUR
CMOCCUR
(NY)
No; Yes
5
What was the name of the other smoking cessation product used?
Smoking Cessation Product Other
Indicate the Other type of product previously used.
Text
CMTRTO
CMTRT
6
Was the smoking cessation product discontinued due to an adverse experience?
Reason Smoking Cessation Product Discontinued
Indicate if the product was discontinued due to an Adverse Experience
Text
CMRSDISC
CMRSDISC
If Yes then CMRSDISC = "ADVERSE EXPERIENCE"
(NY)
No:Yes:
7
What was the last date the product was used?
Last Date Smoking Cessation Product Used
Indicate the last date the product was used. If the product was used with the last 14 days, a complete date must be recorded. Otherwise, partial dates can be recorded.
Date
CMENDAT
CMENDTC
This is the SDTM date for the data collected above. In this example, the applicant only represented whether the product was used in the last 14 days. CMPRESP was populated by the applicant for all pre-specified products. Medication specified as "OTHER" were not considered prespecified.
Row 1:
Shows the subject reported they had not previously used any smoking cessation product ( CMOCCUR ="N") . CMPRESP was included to indicate that the use of smoking cessation product was specifically asked on the CRF.
Rows 2, 5, 8, 11, 14, 17:
Show the subject reported they had used a smoking cessation product (CMOCCUR ="Y") . CMPRESP was included to indicate that the use of a smoking cessation product was specifically asked on the CRF.
Rows 3, 6, 9, 12, 15, 18:
Show the subject reported they had not used nicotine patches (CMOCCUR is "N"). Note: that all other rows for the products not used are not show for simplicity CMPRESP is used to represent that this product was pre-specified.
Rows 4, 7, 10, 13, 16:
Shows the subject reported using the product specified in CMTRT. CMENDTC indicates the last day the product was used. CMPRESP is used to represent that this product was pre-specified. CMOCCUR is Y. Subject ABC-0006 discontinued BUPROPION for an adverse event.
Row 19:
Shows the subject used natural supplement ABC for smoking cessation. Since this product was not specified on the CRF, CMPRESP is null.
Row Captions Debug Message
Remember to keep number agreement between labels and captions.